Press Releases & Statements

July 18, 2016

IPM’s dapivirine ring may offer significant HIV protection when used consistently, new data analyses suggest

Exploratory findings further support the launch of two open-label studies and continued research as IPM pursues regulatory approval DURBAN, South Africa (July 18, 2016) — New data analyses announced... More »

June 29, 2016

IPM Welcomes New Regulatory Affairs Executive Vice President Patricia R. Mayer

New EVP to lead regulatory submission for IPM’s dapivirine vaginal ring for HIV prevention SILVER SPRING, Md. (June 29, 2016) — The International Partnership for Microbicides (IPM) announced today... More »

February 22, 2016

Two Large Studies Show IPM’s Monthly Vaginal Ring Helps Protect Women Against HIV

First long-acting HIV prevention method for women reduced infections by approximately 30% overall, with differences in efficacy by age and level of use; IPM to seek regulatory approval for... More »

December 01, 2015

IPM Receives License from Janssen to Develop FDA-Approved HIV-1 Drug as Microbicide for HIV Prevention

Expands pipeline of next-generation sexual and reproductive health products for women SILVER SPRING, Md. (December 1, 2015) –  The International Partnership for Microbicides (IPM), a nonprofit... More »

November 03, 2015

IPM Initiates First Trial of Novel HIV Prevention Drug for Women

Study in Belgium evaluates safety and tolerability of novel ARV-based women’s health technologySILVER SPRING, Md. (November 3, 2015) – The nonprofit International Partnership for Microbicides (IPM)... More »

Pages